What to know about TrumpRx, the Trump administration’s prescription drug platform
This evening President Trump is planning to launch of TrumpRx, the website that he's touted for months as a platform aimed at lowering prescription drug prices.
This evening President Trump is planning to launch of TrumpRx, the website that he's touted for months as a platform aimed at lowering prescription drug prices.
New Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo Nordisk, following intense competition from multiple pharmaceutical firms,…
A systematic review found that psychotherapy is an effective intervention for easing grief and depression after the death of a loved one, with other approaches, such as expert-facilitated support groups…
In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or area is cancerous. However, in the U.S., between 75% and 80% of…
A new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective disease control in 87.8% of patients with moderate-to-severe atopic dermatitis that was refractory…
A new study published in the Journal of American Medical Association showed that when renal protection is a primary therapeutic objective, starting treatment with an SGLT2 inhibitor (SGLT2i) is linked…
USA: Black women undergoing contrast-enhanced breast MRI are more likely to show higher levels of background parenchymal enhancement (BPE) than White women, despite generally having lower breast density, a new…
A new study published in the journal of Cancer showed that while quitting alcohol may reduce the risk of adenoma, heavy drinking on a regular basis and a higher lifetime…
A new trial from China published in the BMJ journal revealed that telesurgery was non-inferior to standard local robotic surgery for radical prostatectomy and partial nephrectomy in small renal masses.The…
Severe hemolytic disease of the fetus and newborn (HDFN) in early onset can cause fetal anemia, hydrops, and perinatal mortality, often necessitating invasive fetal transfusions. Recent phase 2 results show…